Incyte (INCY) Consolidated Net Income (2010 - 2026)

Incyte (INCY) reported Consolidated Net Income of $303.3 million for Q1 2026, up 91.73% on a YoY basis from $158.2 million in Q1 2025, and up 1.35% quarter-over-quarter from $299.3 million in Q4 2025.

Incyte (INCY) Consolidated Net Income (2010 - 2026) Analysis & Trends

Incyte has reported Consolidated Net Income for 17 years, with the latest figure at $303.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Consolidated Net Income rose 91.73% year-over-year to $303.3 million; the trailing twelve-month figure through Mar 2026 stood at $1.4 billion (up 6631.44% YoY), and the FY2025 full-year result was $1.3 billion, up 3844.96% from the prior year.
  • Consolidated Net Income for Q1 2026 stood at $303.3 million, up from $299.3 million in the prior quarter.
  • The five-year high for Consolidated Net Income was $424.2 million in Q3 2025, with the low at -$444.6 million in Q2 2024.
  • Historically, Consolidated Net Income has averaged $150.6 million across 5 years, with a median of $169.5 million in 2024.
  • The largest YoY upside for Consolidated Net Income was 681.22% in 2024 against a maximum downside of 318.43% in 2024.
  • Incyte's Consolidated Net Income stood at $28.5 million in 2022, then jumped by 606.51% to $201.1 million in 2023, then climbed by 0.07% to $201.2 million in 2024, then surged by 48.74% to $299.3 million in 2025, then grew by 1.35% to $303.3 million in 2026.
  • The last three Consolidated Net Income figures came in at $303.3 million (Q1 2026), $299.3 million (Q4 2025), and $424.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 30.80 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.40 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -14.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.03 Bn
9 Abivax 91.96 Bn 91.96 Bn - -56.48 Mn
10 Incyte 19.62 Bn 15.60 Bn 1.17 Bn 303.33 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 303.33 Mn
Dec 31, 2025 299.28 Mn
Sep 30, 2025 424.17 Mn
Jun 30, 2025 405.00 Mn
Mar 31, 2025 158.20 Mn
Dec 31, 2024 201.21 Mn
Sep 30, 2024 106.46 Mn
Jun 30, 2024 -444.60 Mn
Mar 31, 2024 169.55 Mn
Dec 31, 2023 201.08 Mn
Sep 30, 2023 171.27 Mn
Jun 30, 2023 203.55 Mn
Mar 31, 2023 21.70 Mn
Dec 31, 2022 28.46 Mn
Sep 30, 2022 112.78 Mn
Jun 30, 2022 161.43 Mn
Mar 31, 2022 37.99 Mn
Dec 31, 2021 563.85 Mn
Sep 30, 2021 181.77 Mn
Jun 30, 2021 149.46 Mn